15 December 2016

Tom Nijenhuis, nephrologist and researcher, theme Renal disorders and colleagues demonstrated how sildenafil (Viagra) can prevent damage to the glomerular filter in the kidney. Damage to the glomerular filter occurs in patients with rare primary glomerular diseases, or in patients with secondary glomerular injury due to more common diseases like diabetes, hypertension or vascular injury, which all lead to chronic kidney injury.

Previous research showed that increased activity or overexpression of the Ca2+-permeable ion channel TRPC6 induces deleterious downstream signaling cascades in glomerular podocytes, identifying TRPC6-mediated signaling as a putative treatment target in glomerular disease.

Funded by a Dutch Kidney Foundation- Kolff Career Stimulation grant, and in collaboration with researchers from the Departments of Nephrology, Physiology and Pathology, together with international collaborators, Nijenhuis now identified a TRPC6 inhibitory signaling pathway in the podocyte. This pathway could be activated by sildenafil, thereby preventing glomerular injury in animals models for focal segmental glomerulosclerosis and diabetic nephropathy. Since sildenafil is approved for clinical use and is therefore available for treatment in humans, this study warrants further clinical studies into its beneficial effects in glomerular disease.

The results were recently published in the high-ranking Journal of the American Society of Nephrology.

 

Related news items


A full blood count of COVID-19 patients can predict disease severity

21 December 2020

International research led by the Radboud university medical center makes it easier for healthcare providers to estimate the expected clinical picture.

read more

Willem Mulder joins Radboud University Medical Center

15 December 2020

The department of Internal Medicine of the Radboudumc is extremely happy to announce that on January 1st, 2021 Prof. dr. Willem Mulder (1976) will be joining the department.

read more

Demerger Radboud university medical center and Radboud University is a fact as of 1 January

14 December 2020

Last Friday the board of the Stichting Katholieke Universiteit, together with the Executive Board of Radboud university medical center and the Executive Board of Radboud University, agreed on the ‘decision to separate’.

read more

Vidi grants for Francesco Ciompi, Koen Haak and Laurien Buffart

4 November 2020

They each receive 800,000 euros for their own line of research.

read more

SKU Board Appoints Four New Board Members

16 October 2020

The board of Stichting Katholieke Universiteit (SKU), the supervisory body of Radboud University and Radboud university medical center, has appointed four new board members as of 17 October 2020.

read more